Michael Froehler Archives
Sep. 9, 2021—For a second consecutive year, Vanderbilt's Michael Froehler, MD, PhD, has been elected a member of the board of directors of the Society of NeuroInterventional Surgery (SNIS).
Jul. 29, 2021—For patients in need of acute ischemic stroke treatment, air transport to Vanderbilt University Medical Center is apt to be quicker than ground transport for interhospital transfers of 40 miles or more and for direct-from-scene transfers of 28 miles or more.
Sep. 10, 2020—Michael Froehler, MD, PhD, associate professor of Neurology, Neurological Surgery and Radiology and Radiological Sciences, has been elected a member of the board of directors of the Society of NeuroInterventional Surgery (SNIS).
May. 25, 2017—Vanderbilt University Medical Center’s (VUMC) rapid response in treating stroke patients has received the American Stroke Association’s Honor Roll-Elite Plus recognition for the third consecutive year.
Dec. 8, 2016—The Vanderbilt Stroke Center will participate in a national clinical trial to investigate whether thrombectomies can benefit stroke patients when performed beyond the currently recommended window of time for intervention.
Mar. 12, 2015—For nearly a decade, Vanderbilt University Medical Center has been at the forefront of stroke treatment using endovascular neuro-interventional techniques. Similar to procedures done for a heart attack, interventional stroke treatment employs suction and retrievers to remove blood clots.
Oct. 9, 2014—Conventional therapy for patients diagnosed with retinoblastoma, the most common ocular cancer in children, includes systemic chemotherapy, external beam radiation and/or surgical removal of the eye. Doctors at Vanderbilt University Medical Center are on track to radically change the way the disease is treated using an emerging therapeutic approach called intra-arterial chemotherapy, or IA chemo.
Oct. 17, 2013—Vanderbilt University Medical Center has joined a national network funded by the National Institutes of Health to streamline multi-site clinical trials focused on key interventions in stroke prevention, treatment and recovery.